668.06
前日終値:
$665.67
開ける:
$667.7
24時間の取引高:
566.67K
Relative Volume:
0.76
時価総額:
$83.73B
収益:
$344.58B
当期純損益:
$2.83B
株価収益率:
30.59
EPS:
21.84
ネットキャッシュフロー:
$1.63B
1週間 パフォーマンス:
+1.04%
1か月 パフォーマンス:
+7.60%
6か月 パフォーマンス:
+36.83%
1年 パフォーマンス:
+24.44%
Mckesson Corporation Stock (MCK) Company Profile
名前
Mckesson Corporation
セクター
電話
972-446-4800
住所
6555 STATE HIGHWAY 161, IRVING, TX
MCK を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MCK
Mckesson Corporation
|
668.06 | 83.73B | 344.58B | 2.83B | 1.63B | 21.84 |
![]()
COR
Cencora Inc
|
275.21 | 53.07B | 303.19B | 1.40B | -638.10M | 7.03 |
![]()
CAH
Cardinal Health Inc
|
136.44 | 33.23B | 222.16B | 1.31B | -486.00M | 5.36 |
![]()
HSIC
Henry Schein Inc
|
68.62 | 8.52B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
PDCO
Patterson Companies Inc
|
31.21 | 2.75B | 6.55B | 155.22M | -823.13M | 1.71 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-04 | 再開されました | Mizuho | Neutral |
2024-11-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
2024-09-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2024-09-05 | 繰り返されました | Leerink Partners | Outperform |
2024-08-08 | 繰り返されました | Mizuho | Neutral |
2024-02-26 | 開始されました | Leerink Partners | Outperform |
2024-01-03 | 開始されました | Barclays | Overweight |
2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
2023-03-31 | 開始されました | Citigroup | Buy |
2022-08-22 | 再開されました | Morgan Stanley | Overweight |
2022-07-06 | ダウングレード | Argus | Buy → Hold |
2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
2022-04-01 | 再開されました | Credit Suisse | Outperform |
2022-02-04 | ダウングレード | Deutsche Bank | Buy → Hold |
2022-01-07 | アップグレード | Credit Suisse | Neutral → Outperform |
2021-11-02 | 繰り返されました | Barclays | Overweight |
2021-11-02 | 繰り返されました | BofA Securities | Buy |
2021-11-02 | 繰り返されました | Evercore ISI | Outperform |
2021-11-02 | 繰り返されました | Jefferies | Buy |
2021-03-30 | アップグレード | Argus | Hold → Buy |
2020-11-02 | アップグレード | Barclays | Equal Weight → Overweight |
2020-08-04 | アップグレード | Deutsche Bank | Hold → Buy |
2020-05-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2020-05-15 | アップグレード | UBS | Neutral → Buy |
2020-04-23 | 再開されました | Credit Suisse | Neutral |
2020-03-18 | アップグレード | Goldman | Neutral → Buy |
2020-03-13 | アップグレード | Guggenheim | Neutral → Buy |
2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
2020-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2019-09-12 | 開始されました | Deutsche Bank | Hold |
2019-08-05 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2019-07-22 | 開始されました | Guggenheim | Neutral |
2019-01-17 | 開始されました | UBS | Neutral |
2018-10-26 | 繰り返されました | Barclays | Equal Weight |
2018-07-20 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2018-05-29 | 繰り返されました | Leerink Partners | Mkt Perform |
2018-03-08 | 開始されました | Barclays | Equal Weight |
2018-02-27 | 再開されました | BofA/Merrill | Buy |
2018-02-02 | 繰り返されました | Mizuho | Neutral |
2018-01-24 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Mckesson Corporation (MCK) 最新ニュース
Is McKesson Corporation (MCK) the Best S&P 500 Stock to Buy for Dividend Growth? - Insider Monkey
McKesson stock soars to all-time high, hits $672 - Investing.com
McKesson stock soars to all-time high, hits $672 By Investing.com - Investing.com South Africa
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy? - Yahoo Finance
Q4 Earnings Outperformers: McKesson (NYSE:MCK) And The Rest Of The Healthcare Providers & Services Stocks - Financial Content
Deutsche Bank Raises Price Target on McKesson to $700 From $663 - Marketscreener.com
McKesson (MCK): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock - Yahoo Finance
McKesson Careers | The future of health starts with you. - McKesson
With 89% institutional ownership, McKesson Corporation (NYSE:MCK) is a favorite amongst the big guns - Yahoo Finance
McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025 (NYSE:MCK) - Seeking Alpha
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note - MSN
Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS - CNBC
Is McKesson Corporation (MCK) The Best Healthcare Dividend Stock to Invest in? - Insider Monkey
McKesson (MCK) and Visa (V) Are 2 Dividend Growth Stocks to Buy For a Lifetime of Passive Income - 24/7 Wall St.
McKesson stock soars to all-time high of $667.08 amid robust growth - Investing.com Australia
McKesson stock soars to all-time high of $667.08 amid robust growth By Investing.com - Investing.com South Africa
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
McKesson Stock Outshines Alphabet Amid Economic Volatility - Evrim Ağacı
Fortune 50 company puts local facility in midst of closing up for sale - The Business Journals
Telehealth Market Set to Witness Significant Growth by 2025-2032: McKesson Corporation, Cisco Systems, Inc, - EIN News
With 89% ownership of the shares, McKesson Corporation (NYSE:MCK) is heavily dominated by institutional owners - Simply Wall St
American Express Chief Legal Officer earns $11 million compensation in 2024 - ETLegalworld
Wells Fargo Adjusts Price Target on McKesson to $691 From $641, Maintains Equalweight Rating - Marketscreener.com
McKesson Sees Its Composite Rating Rise To 96 - Investor's Business Daily
McKesson (MCK) Advances While Market Declines: Some Information for Investors - Yahoo Finance
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Is Trending Stock McKesson Corporation (MCK) a Buy Now? - MSN
GS1 US Presents Upcoming Free Webinar: How McKesson and Target Are Electrifying Their Supply Chains Using EPCIS to Share Product Data - Yahoo Finance
McKesson Co. (NYSE:MCK) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
McKesson Gets IBD Stock Rating Upgrade - Investor's Business Daily
Ambulatory Infusion Center Market Projected To Witness Substantial Growth 2025-2032:McKesson - EIN News
McKesson stock soars to all-time high of $653.97 amid robust growth By Investing.com - Investing.com South Africa
McKesson stock soars to all-time high of $653.97 amid robust growth - Investing.com India
Is McKesson Stock Outperforming the Dow? - Nasdaq
Is McKesson Stock Outperforming The Dow? - Barchart
McKesson Corporation (MCK) Surged on Increased Guidance - MSN
McKesson CEO Tyler Brian S. sells $5.68 million in stock - Investing.com India
Leerink Partners Adjusts Price Target on McKesson to $732 From $690, Keeps Outperform Rating - Marketscreener.com
Lumata Health Secures $23 Million Series B Funding Round Co-Led By Lrvhealth, Mckesson Ventures, Cencora Ventures - Marketscreener.com
McKesson Keeps Growing, Eyeing Bigger Future - Yahoo Finance
McKesson to Acquire Controlling Interest in PRISM Vision Holdings - The Healthcare Technology Report.
Global Healthcare Mobility Solutions Market to Exhibit Tremendous Growth at a CAGR of ~21% by 2032 | DelveInsight - GlobeNewswire Inc.
McKesson CEO Tyler sells $5.6 million in common stock By Investing.com - Investing.com South Africa
Mckesson Corporation (MCK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):